Regeneron Pharmaceuticals, Inc.
ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF
Last updated:
Abstract:
Antibodies, portions, and fusion proteins thereof to CD63 are provided. Also provided are nucleic acid sequences encoding same. Also provided are compositions comprising and methods of using same, e.g., for treating a patient in need thereof.
Status:
Application
Type:
Utility
Filling date:
17 May 2019
Issue date:
18 Mar 2021